CARDIFF ONCOLOGY, INC. Interest Income (Expense), Net
CARDIFF ONCOLOGY, INC. (CRDF) reported Interest Income (Expense), Net of $35.28 thousand for the 3-month period ending 2018-06-30, per its 10-Q filed 2018-08-03.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNet · last filed 2018-08-03
- CARDIFF ONCOLOGY, INC. interest income (expense), net for the quarter ending 2018-06-30 was $35.28K.
- CARDIFF ONCOLOGY, INC. interest income (expense), net for the quarter ending 2018-03-31 was -$2.46K.
- CARDIFF ONCOLOGY, INC. interest income (expense), net for the quarter ending 2017-09-30 was -$16.47K.
- CARDIFF ONCOLOGY, INC. interest income (expense), net for the quarter ending 2017-06-30 was -$431.87K.
- CARDIFF ONCOLOGY, INC. interest income (expense), net for fiscal 2016 was -$1.38M.
- CARDIFF ONCOLOGY, INC. interest income (expense), net for fiscal 2015 was -$1.47M.
- CARDIFF ONCOLOGY, INC. interest income (expense), net for fiscal 2014 was -$831.02K.
| Period end | Interest Income (Expense), Net 3 month | Interest Income (Expense), Net 6 month | Interest Income (Expense), Net 9 month | Interest Income (Expense), Net 12 month |
|---|---|---|---|---|
| 2018-06-30 | $35.28K 10-Q · filed 2018-08-03 | $32.81K 10-Q · filed 2018-08-03 | ||
| 2018-03-31 | -$2.46K 10-Q · filed 2018-05-08 | |||
| 2017-09-30 | -$16.47K 10-Q · filed 2017-11-09 | -$448.34K derived: sum of 2 quarters · filed 2018-08-03 | -$877.74K 10-Q · filed 2017-11-09 | -$1.29M derived: sum of 4 quarters · filed 2018-08-03 |
| 2017-06-30 | -$431.87K 10-Q · filed 2018-08-03 | -$861.27K 10-Q · filed 2018-08-03 | -$1.27M derived: sum of 3 quarters · filed 2018-08-03 | -$1.62M derived: sum of 4 quarters · filed 2018-08-03 |
| 2017-03-31 | -$429.40K 10-Q · filed 2018-05-08 | -$837.39K derived: sum of 2 quarters · filed 2018-05-08 | -$1.19M derived: sum of 3 quarters · filed 2018-05-08 | -$1.47M derived: sum of 4 quarters · filed 2018-05-08 |
| 2016-12-31 | -$407.99K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | -$762.98K derived: sum of 2 quarters · filed 2017-11-09 | -$1.04M derived: sum of 3 quarters · filed 2017-11-09 | -$1.38M 10-K · filed 2017-03-15 |
| 2016-09-30 | -$354.99K 10-Q · filed 2017-11-09 | -$629.90K derived: sum of 2 quarters · filed 2017-11-09 | -$967.52K 10-Q · filed 2017-11-09 | -$1.34M derived: sum of 4 quarters · filed 2017-11-09 |
| 2016-06-30 | -$274.91K 10-Q · filed 2017-08-09 | -$612.53K 10-Q · filed 2017-08-09 | -$980.67K derived: sum of 3 quarters · filed 2017-08-09 | -$1.32M derived: sum of 4 quarters · filed 2017-08-09 |
| 2016-03-31 | -$337.62K 10-Q · filed 2017-05-10 | -$705.76K derived: sum of 2 quarters · filed 2017-05-10 | -$1.04M derived: sum of 3 quarters · filed 2017-05-10 | -$1.42M derived: sum of 4 quarters · filed 2017-05-10 |
| 2015-12-31 | -$368.14K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | -$703.50K derived: sum of 2 quarters · filed 2017-03-15 | -$1.08M derived: sum of 3 quarters · filed 2017-03-15 | -$1.47M 10-K · filed 2017-03-15 |
| 2015-09-30 | -$335.36K 10-Q · filed 2016-11-09 | -$716.61K derived: sum of 2 quarters · filed 2016-11-09 | -$1.10M 10-Q · filed 2016-11-09 | |
| 2015-06-30 | -$381.25K 10-Q · filed 2016-08-04 | -$764.72K 10-Q · filed 2016-08-04 | ||
| 2015-03-31 | -$383.47K 10-Q · filed 2016-05-10 | |||
| 2014-12-31 | -$831.02K 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |